3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Meningioma
1
Lung Neoplasms
1
Ependymoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
lutetium Lu 177 dotatate
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Radiosurgery
3
gallium Ga 68 dotatate
2
abemaciclib
2
Ga(III)-DOTATOC
2
Bevacizumab
2
ribociclib
1
regorafenib
1
pembrolizumab
1
olaparib
1
neratinib
1
capivasertib
1
cabozantinib
1
brigatinib
1
X-Rays
1
Watchful Waiting
1
Tablets
1
Surveys and Questionnaires
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Protons
1
Proton Therapy
1
Photons
1
Observation
1
ONC206
1
Nivolumab
1
Mental Status and Dementia Tests
1
Lysine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Meningioma
×
brigatinib
×
90 days
×
Clear all
NCT04374305
2026-05-06
INTUITT-NF2
Massachusetts General Hospital
Phase 2
Recruiting
109 enrolled